Found 109 hits for UniProtKB: O95622 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144001
(3-{4-[1-(2',4'-Dichloro-biphenyl-4-ylcarbamoyl)-he...)Show SMILES CCCCCCC(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccc(Cl)cc1Cl Show InChI InChI=1S/C30H32Cl2N2O5/c1-2-3-4-5-6-27(39-24-14-9-21(10-15-24)29(37)33-18-17-28(35)36)30(38)34-23-12-7-20(8-13-23)25-16-11-22(31)19-26(25)32/h7-16,19,27H,2-6,17-18H2,1H3,(H,33,37)(H,34,38)(H,35,36) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144020
(3-{4-[1-(4-Benzofuran-2-yl-phenylcarbamoyl)-heptyl...)Show SMILES CCCCCCC(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C32H34N2O6/c1-2-3-4-5-10-28(39-26-17-13-23(14-18-26)31(37)33-20-19-30(35)36)32(38)34-25-15-11-22(12-16-25)29-21-24-8-6-7-9-27(24)40-29/h6-9,11-18,21,28H,2-5,10,19-20H2,1H3,(H,33,37)(H,34,38)(H,35,36) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144015
(3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-octyl]...)Show SMILES CCCCCCC(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C33H36N2O5/c1-2-3-4-5-9-27(21-23-11-13-25(14-12-23)32(38)34-20-19-31(36)37)33(39)35-28-17-15-24(16-18-28)30-22-26-8-6-7-10-29(26)40-30/h6-8,10-18,22,27H,2-5,9,19-21H2,1H3,(H,34,38)(H,35,39)(H,36,37) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144008
(3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-2-(4-t...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C37H36N2O5/c1-37(2,3)29-16-12-25(13-17-29)31(22-24-8-10-27(11-9-24)35(42)38-21-20-34(40)41)36(43)39-30-18-14-26(15-19-30)33-23-28-6-4-5-7-32(28)44-33/h4-19,23,31H,20-22H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144002
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(2',4'-dichloro-bi...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccc(Cl)cc1Cl Show InChI InChI=1S/C35H34Cl2N2O4/c1-35(2,3)26-12-8-24(9-13-26)30(20-22-4-6-25(7-5-22)33(42)38-19-18-32(40)41)34(43)39-28-15-10-23(11-16-28)29-17-14-27(36)21-31(29)37/h4-17,21,30H,18-20H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144008
(3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-2-(4-t...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C37H36N2O5/c1-37(2,3)29-16-12-25(13-17-29)31(22-24-8-10-27(11-9-24)35(42)38-21-20-34(40)41)36(43)39-30-18-14-26(15-19-30)33-23-28-6-4-5-7-32(28)44-33/h4-19,23,31H,20-22H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced monkey adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144003
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-trifluoromethox...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 Show InChI InChI=1S/C30H31F3N2O5/c1-29(2,3)22-10-8-20(9-11-22)25(28(39)35-23-12-14-24(15-13-23)40-30(31,32)33)18-19-4-6-21(7-5-19)27(38)34-17-16-26(36)37/h4-15,25H,16-18H2,1-3H3,(H,34,38)(H,35,39)(H,36,37) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144016
(3-{4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-pheny...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C34H34N2O5/c1-34(2,3)27-15-9-25(10-16-27)31(41-29-19-13-26(14-20-29)32(39)35-22-21-30(37)38)33(40)36-28-17-11-24(12-18-28)23-7-5-4-6-8-23/h4-20,31H,21-22H2,1-3H3,(H,35,39)(H,36,40)(H,37,38) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 144 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144009
(3-{4-[1-(4-tert-Butyl-cyclohexyl)-3-(4-trifluorome...)Show SMILES CC(C)(C)[C@H]1CC[C@@H](CC1)N(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 |wU:4.3,wD:7.10,(10.18,2.9,;9.39,1.56,;8.05,2.34,;8.62,.21,;10.74,.78,;12.08,1.53,;13.41,.77,;13.41,-.77,;12.07,-1.54,;10.74,-.77,;14.74,-1.54,;14.74,-3.07,;13.39,-3.86,;12.07,-3.1,;10.74,-3.86,;10.74,-5.4,;12.07,-6.17,;13.41,-5.4,;9.41,-6.19,;9.43,-7.72,;8.06,-5.42,;6.74,-6.2,;5.4,-5.44,;4.07,-6.23,;2.73,-5.47,;4.07,-7.77,;16.06,-.77,;16.06,.77,;17.39,-1.54,;18.71,-.77,;20.04,-1.53,;21.38,-.77,;21.36,.78,;22.71,1.56,;22.7,3.09,;21.17,3.11,;24.23,3.11,;22.71,4.62,;20.04,1.55,;18.71,.77,)| Show InChI InChI=1S/C29H36F3N3O5/c1-28(2,3)21-8-12-23(13-9-21)35(27(39)34-22-10-14-24(15-11-22)40-29(30,31)32)18-19-4-6-20(7-5-19)26(38)33-17-16-25(36)37/h4-7,10-11,14-15,21,23H,8-9,12-13,16-18H2,1-3H3,(H,33,38)(H,34,39)(H,36,37)/t21-,23- | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 254 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144004
(3-{4-[2-(Biphenyl-4-ylcarbamoyl)-2-(4-tert-butyl-p...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C35H36N2O4/c1-35(2,3)29-17-13-27(14-18-29)31(23-24-9-11-28(12-10-24)33(40)36-22-21-32(38)39)34(41)37-30-19-15-26(16-20-30)25-7-5-4-6-8-25/h4-20,31H,21-23H2,1-3H3,(H,36,40)(H,37,41)(H,38,39) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144012
(4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-phenyl)-...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)Nc1nnn[nH]1)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C32H30N6O3/c1-32(2,3)25-15-9-23(10-16-25)28(30(40)33-26-17-11-22(12-18-26)21-7-5-4-6-8-21)41-27-19-13-24(14-20-27)29(39)34-31-35-37-38-36-31/h4-20,28H,1-3H3,(H,33,40)(H2,34,35,36,37,38,39) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 317 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144006
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(quinolin-3-ylcarb...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1cnc2ccccc2c1 Show InChI InChI=1S/C32H33N3O4/c1-32(2,3)25-14-12-22(13-15-25)27(31(39)35-26-19-24-6-4-5-7-28(24)34-20-26)18-21-8-10-23(11-9-21)30(38)33-17-16-29(36)37/h4-15,19-20,27H,16-18H2,1-3H3,(H,33,38)(H,35,39)(H,36,37) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 610 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144005
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-hydroxymethyl-p...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(CO)cc1 Show InChI InChI=1S/C30H34N2O5/c1-30(2,3)24-12-10-22(11-13-24)26(29(37)32-25-14-6-21(19-33)7-15-25)18-20-4-8-23(9-5-20)28(36)31-17-16-27(34)35/h4-15,26,33H,16-19H2,1-3H3,(H,31,36)(H,32,37)(H,34,35) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144011
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-ethyl-phenylcar...)Show SMILES CCc1ccc(NC(=O)C(Cc2ccc(cc2)C(=O)NCCC(O)=O)c2ccc(cc2)C(C)(C)C)cc1 Show InChI InChI=1S/C31H36N2O4/c1-5-21-8-16-26(17-9-21)33-30(37)27(23-12-14-25(15-13-23)31(2,3)4)20-22-6-10-24(11-7-22)29(36)32-19-18-28(34)35/h6-17,27H,5,18-20H2,1-4H3,(H,32,36)(H,33,37)(H,34,35) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144019
(3-{4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-pheny...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)NCC(F)C(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C34H33FN2O5/c1-34(2,3)26-15-9-24(10-16-26)30(32(39)37-27-17-11-23(12-18-27)22-7-5-4-6-8-22)42-28-19-13-25(14-20-28)31(38)36-21-29(35)33(40)41/h4-20,29-30H,21H2,1-3H3,(H,36,38)(H,37,39)(H,40,41) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144000
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-piperidin-1-yl-...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)N1CCCCC1 Show InChI InChI=1S/C34H41N3O4/c1-34(2,3)27-13-11-25(12-14-27)30(23-24-7-9-26(10-8-24)32(40)35-20-19-31(38)39)33(41)36-28-15-17-29(18-16-28)37-21-5-4-6-22-37/h7-18,30H,4-6,19-23H2,1-3H3,(H,35,40)(H,36,41)(H,38,39) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144018
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-pyrazol-1-yl-ph...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-n1cccn1 Show InChI InChI=1S/C32H34N4O4/c1-32(2,3)25-11-9-23(10-12-25)28(21-22-5-7-24(8-6-22)30(39)33-19-17-29(37)38)31(40)35-26-13-15-27(16-14-26)36-20-4-18-34-36/h4-16,18,20,28H,17,19,21H2,1-3H3,(H,33,39)(H,35,40)(H,37,38) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144014
(3-{4-[2-(4-tert-Butyl-phenyl)-3-(4-ethyl-piperazin...)Show SMILES CCN1CCN(CC1)C(=O)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)c1ccc(cc1)C(C)(C)C Show InChI InChI=1S/C29H39N3O4/c1-5-31-16-18-32(19-17-31)28(36)25(22-10-12-24(13-11-22)29(2,3)4)20-21-6-8-23(9-7-21)27(35)30-15-14-26(33)34/h6-13,25H,5,14-20H2,1-4H3,(H,30,35)(H,33,34) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144010
(3-{4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-pheny...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)NCC(O)C(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C34H34N2O6/c1-34(2,3)26-15-9-24(10-16-26)30(32(39)36-27-17-11-23(12-18-27)22-7-5-4-6-8-22)42-28-19-13-25(14-20-28)31(38)35-21-29(37)33(40)41/h4-20,29-30,37H,21H2,1-3H3,(H,35,38)(H,36,39)(H,40,41) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144013
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-trifluoromethox...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(COC(F)(F)F)cc1 Show InChI InChI=1S/C31H33F3N2O5/c1-30(2,3)24-12-10-22(11-13-24)26(18-20-4-8-23(9-5-20)28(39)35-17-16-27(37)38)29(40)36-25-14-6-21(7-15-25)19-41-31(32,33)34/h4-15,26H,16-19H2,1-3H3,(H,35,39)(H,36,40)(H,37,38) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144017
(3-{4-[2-(4-tert-Butyl-phenyl)-3-oxo-3-(4-p-tolyl-p...)Show SMILES Cc1ccc(cc1)N1CCN(CC1)C(=O)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)c1ccc(cc1)C(C)(C)C Show InChI InChI=1S/C34H41N3O4/c1-24-5-15-29(16-6-24)36-19-21-37(22-20-36)33(41)30(26-11-13-28(14-12-26)34(2,3)4)23-25-7-9-27(10-8-25)32(40)35-18-17-31(38)39/h5-16,30H,17-23H2,1-4H3,(H,35,40)(H,38,39) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50144007
(3-{4-[2-(4-tert-Butyl-phenyl)-2-(3-ethyl-phenylcar...)Show SMILES CCc1cccc(NC(=O)C(Cc2ccc(cc2)C(=O)NCCC(O)=O)c2ccc(cc2)C(C)(C)C)c1 Show InChI InChI=1S/C31H36N2O4/c1-5-21-7-6-8-26(19-21)33-30(37)27(23-13-15-25(16-14-23)31(2,3)4)20-22-9-11-24(12-10-22)29(36)32-18-17-28(34)35/h6-16,19,27H,5,17-18,20H2,1-4H3,(H,32,36)(H,33,37)(H,34,35) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| >2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 1/2/3/4/5/6/7/8/9
(Homo sapiens (Human)) | BDBM50227472
(CHEMBL2372272)Show SMILES [#6]-[#6]-[#8]-c1ccc(-[#6]-[#6@H]-2-[#7]-[#6](=O)-[#6]C3([#6]-[#6]-[#6]-[#6]-[#6]3)[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H](-[#7]-[#6](=O)-[#6@H](-[#6]-c3ccccc3)-[#7]-[#6]-2=O)-[#6](-[#6])-[#6])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](-[#7])=O)cc1 Show InChI InChI=1S/C48H71N11O9/c1-4-68-32-19-17-31(18-20-32)26-35-43(64)57-36(25-30-13-7-5-8-14-30)45(66)59-40(29(2)3)46(67)58-37(27-38(49)60)44(65)56-34(42(63)55-33(41(50)62)16-12-24-53-47(51)52)15-11-23-48(28-39(61)54-35)21-9-6-10-22-48/h5,7-8,13-14,17-20,29,33-37,40H,4,6,9-12,15-16,21-28H2,1-3H3,(H2,49,60)(H2,50,62)(H,54,61)(H,55,63)(H,56,65)(H,57,64)(H,58,67)(H,59,66)(H4,51,52,53)/t33-,34?,35+,36-,37-,40-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| 4.40E+6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Smith Kline & French Laboratories
Curated by ChEMBL
| Assay Description In vitro antagonist activity of the compound was measured by inhibition of vasopressin-stimulated adenylate cyclase in renal medullary preparation in... |
J Med Chem 31: 1487-9 (1988)
BindingDB Entry DOI: 10.7270/Q2S46QZN |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50090529
(2-[1-(Naphthalene-1-sulfonyl)-1H-indol-6-yl]-octah...)Show SMILES O=S(=O)(c1cccc2ccccc12)n1ccc2ccc(cc12)N1CCN2CCCC2C1 Show InChI InChI=1S/C25H25N3O2S/c29-31(30,25-9-3-6-19-5-1-2-8-23(19)25)28-14-12-20-10-11-21(17-24(20)28)27-16-15-26-13-4-7-22(26)18-27/h1-3,5-6,8-12,14,17,22H,4,7,13,15-16,18H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS Allelix Corp.
Curated by ChEMBL
| Assay Description Antagonistic activity of the compound evaluated in adenylyl cyclase assay |
Bioorg Med Chem Lett 10: 1719-21 (2000)
BindingDB Entry DOI: 10.7270/Q2BP021W |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128187
((1R,3R)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128192
((1S,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](CC(=O)NO)C=C1 |c:20| Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128210
((1R,3R)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](CC(=O)NO)C1 Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128207
((1S,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@@H](CC(=O)NO)C=C1 |c:20| Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128209
((1R,3S)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)Show SMILES Nc1ncnc2n(cnc12)[C@H]1C[C@H](CC(=O)NO)C=C1 |c:20| Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128203
((1R,3S)-3-(6-Amino-purin-9-yl)-cyclopentanecarboxy...)Show InChI InChI=1S/C11H14N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h4-7,19H,1-3H2,(H,16,18)(H2,12,13,14)/t6-,7+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128199
((1S,3S)-4-(6-Amino-purin-9-yl)-cyclopent-2-enecarb...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](C=C1)C(=O)NO |c:15| Show InChI InChI=1S/C11H12N6O2/c12-9-8-10(14-4-13-9)17(5-15-8)7-2-1-6(3-7)11(18)16-19/h1-2,4-7,19H,3H2,(H,16,18)(H2,12,13,14)/t6-,7-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119826
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells |
Bioorg Med Chem Lett 12: 3085-8 (2002)
BindingDB Entry DOI: 10.7270/Q2XW4J5B |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119826
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119826
(5-(6-Amino-purin-9-yl)-pentanoic acid hydroxyamide...)Show InChI InChI=1S/C10H14N6O2/c11-9-8-10(13-5-12-9)16(6-14-8)4-2-1-3-7(17)15-18/h5-6,18H,1-4H2,(H,15,17)(H2,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119832
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119832
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells |
Bioorg Med Chem Lett 12: 3085-8 (2002)
BindingDB Entry DOI: 10.7270/Q2XW4J5B |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119832
(4-(6-Amino-purin-9-yl)-N-hydroxy-butyramide | CHEM...)Show InChI InChI=1S/C9H12N6O2/c10-8-7-9(12-4-11-8)15(5-13-7)3-1-2-6(16)14-17/h4-5,17H,1-3H2,(H,14,16)(H2,10,11,12) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 7.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128188
((1S,3R)-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl]-...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](CC(O)=O)C=C1 |c:19| Show InChI InChI=1S/C12H13N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h1-2,5-8H,3-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 8.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128206
((1S,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 9.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119858
(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)OCC(=O)NO Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.08E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128191
(2-[3-(6-Amino-purin-9-yl)-cyclopentyloxy]-N-hydrox...)Show SMILES Nc1ncnc2n(cnc12)[C@H]1CC[C@@H](C1)OCC(=O)NO Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.08E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119858
(2-[(S)-3-((S)-6-Amino-purin-9-yl)-cyclopentyloxy]-...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1CC[C@@H](C1)OCC(=O)NO Show InChI InChI=1S/C12H16N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.08E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128205
(2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyloxy]-N-h...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@@H](OCC(=O)NO)C=C1 |c:21| Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.36E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119855
(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](OCC(=O)NO)C=C1 |c:21| Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.36E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119855
(2-{[(1S,4R)-4-(6-amino-9H-purin-9-yl)cyclopent-2-e...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](OCC(=O)NO)C=C1 |c:21| Show InChI InChI=1S/C12H14N6O3/c13-11-10-12(15-5-14-11)18(6-16-10)7-1-2-8(3-7)21-4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.36E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against Type V Adenyl Cyclase enzyme |
Bioorg Med Chem Lett 12: 3089-92 (2002)
BindingDB Entry DOI: 10.7270/Q2T43SFX |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119844
(2-{[2-(6-Amino-purin-9-yl)-ethyl]-methyl-amino}-N-...)Show InChI InChI=1S/C10H15N7O2/c1-16(4-7(18)15-19)2-3-17-6-14-8-9(11)12-5-13-10(8)17/h5-6,19H,2-4H2,1H3,(H,15,18)(H2,11,12,13) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1.53E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells |
Bioorg Med Chem Lett 12: 3085-8 (2002)
BindingDB Entry DOI: 10.7270/Q2XW4J5B |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128204
((1R,3R)-2-[4-(6-Amino-purin-9-yl)-cyclopent-2-enyl...)Show SMILES Nc1ncnc2n(cnc12)[C@@H]1C[C@H](CC(=O)NO)C=C1 |c:20| Show InChI InChI=1S/C12H14N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h1-2,5-8,20H,3-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.63E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128202
((1R,3S)-2-[3-(6-Amino-purin-9-yl)-cyclopentyl]-N-h...)Show InChI InChI=1S/C12H16N6O2/c13-11-10-12(15-5-14-11)18(6-16-10)8-2-1-7(3-8)4-9(19)17-20/h5-8,20H,1-4H2,(H,17,19)(H2,13,14,15)/t7-,8+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.51E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50128195
((1R,3R)-[3-(6-Amino-purin-9-yl)-cyclopentyl]-aceti...)Show InChI InChI=1S/C12H15N5O2/c13-11-10-12(15-5-14-11)17(6-16-10)8-2-1-7(3-8)4-9(18)19/h5-8H,1-4H2,(H,18,19)(H2,13,14,15)/t7-,8-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.88E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibitory activity against recombinant human adenylate cyclase 5 expressed in HEK293 cells. |
J Med Chem 46: 2177-86 (2003)
Article DOI: 10.1021/jm0205604 BindingDB Entry DOI: 10.7270/Q2M32V44 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 5
(Homo sapiens (Human)) | BDBM50119842
(6-(6-Amino-purin-9-yl)-hexanoic acid hydroxyamide ...)Show InChI InChI=1S/C11H16N6O2/c12-10-9-11(14-6-13-10)17(7-15-9)5-3-1-2-4-8(18)16-19/h6-7,19H,1-5H2,(H,16,18)(H2,12,13,14) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 3.54E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of recombinant human adenylate cyclase 5 expressed in HEK293 cells |
Bioorg Med Chem Lett 12: 3085-8 (2002)
BindingDB Entry DOI: 10.7270/Q2XW4J5B |
More data for this Ligand-Target Pair | |